About Joyce Varughese, MDfemale
Dr. Joyce Varughese has been in practice since 2013. Prior to coming to Saint Peter’s, Dr. Varughese was an Assistant Professor of Clinical Obstetrics, Gynecology and Reproductive Medicine, and an Attending Physician at Stony Brook School of Medicine and Stony Brook Hospital in New York. She previously served as a Clinical Instructor in the Department of Obstetrics and Gynecology and Reproductive Sciences at Yale University, New Haven, Connecticut.
Dr. Varughese has received numerous awards and has presented her findings at national meetings and in peer-reviewed journals. she graduated with a Bachelor of Arts, Magna Cum Laude, from Harvard University, Cambridge, Massachusetts, and went on to earn her Doctor of Medicine from Albert Einstein College of Medicine of Yeshiva University, Bronx, New York. Dr. Varughese completed her Residency in Obstetrics and Gynecology at Yale-New Haven Hosptial/ Yale University and also completed her Fellowship in Gynecologic Oncology at Yale University.
Dr. Varughese is committed to a multidisciplinary approach to the treatment and management of cancer, including incorporating complementary therapies. She believes in keeping the referring physician as part of the team, especially during surveillance. Dr. Varughese is also trained in robotic surgery.
1. Zhao S, Choi M, Overton J, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, et al. Landscape of somatic single nucleotide and copy number mutations in uterine serous carcinoma. Proceedings of the National Academy of Sciences USA, 2013 Feb; 110(8):2916-21. PMID:23359684
2. Varughese J, Hui P, Lu L, Yu H, Schwartz PE. Clear Cell Cancer of the Uterine Corpus: the Association of Clinicopathologic Parameters and Treatment on Disease Progression. Journal of Oncology, 2011: 628084. Epub 2011 Nov 30. PMID:22187554
3. Varughese J, Cocco E, Bellone S, Buza N, Ratner E, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody. American Journal of Obstetrics and Gynecology, 2011 Dec;205(6):567.e1-7. PMID:21889762
- Specialty: GYN Oncology
- Specialty2: Gynecology
- Specialty3: Ovarian Cancer
- Specialty4: Women's Health
- Education: Albert Einstein College of Medicine of Yeshiva University
- Residency: Yale-New Haven Hospital/Yale University
- Fellowship: Yale University